First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

Holleman MS, van Tinteren H, Groen HJM, Al MJ, Uyl-de Groot CA

OncoTargets and Therapy 2019, 12:1413-1421

Published Date: 20 February 2019